Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach.
Katona G, Balogh GT, Dargó G, Gáspár R, Márki Á, Ducza E, Sztojkov-Ivanov A, Tömösi F, Kecskeméti G, Janáky T, Kiss T, Ambrus R, Pallagi E, Szabó-Révész P, Csóka I.
Katona G, et al. Among authors: balogh gt.
Pharmaceutics. 2020 Jan 25;12(2):97. doi: 10.3390/pharmaceutics12020097.
Pharmaceutics. 2020.
PMID: 31991767
Free PMC article.